Skip to content

Immunovant, Inc. IMVT Incentive stock program, shares reserved for future grants (in shares)

Incentive stock program, shares reserved for future grants (in shares) at other companies

Merck & Co. logo
Merck & Co.MRK
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$7.26B+74.2%
Enterprise value$6.35B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0.0×
Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.

The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s incentive stock program, shares reserved for future grants (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immunovant, Inc.'s incentive stock program, shares reserved for future grants (in shares)?
Immunovant, Inc. (IMVT) reported incentive stock program, shares reserved for future grants (in shares) of $7.63M in Q4 2025.
How has Immunovant, Inc.'s incentive stock program, shares reserved for future grants (in shares) changed year-over-year?
Immunovant, Inc.'s incentive stock program, shares reserved for future grants (in shares) increased by 28.6% year-over-year, from $5.94M to $7.63M.
What is the long-term trend for Immunovant, Inc.'s incentive stock program, shares reserved for future grants (in shares)?
Over 4 years (2021 to 2025), Immunovant, Inc.'s incentive stock program, shares reserved for future grants (in shares) has grown at a 35.6% compound annual growth rate (CAGR), from $1.78M to $6.03M.